Earlier this month, Health Canada s Chief Medical Adviser Dr. Supriya Sharma also doubted that a vaccine would be ready for children by the time school starts in September, noting trials with younger participants tend to take more time. It s not inconceivable that we might have some data in the summer, and potentially by the end of this calendar year we might have some indications in children, but that s still pretty optimistic, Sharma said.
Recruitment, retainment an issue with kids
Moderna has said its Phase 2/3 study would involve 6,750 healthy pediatric participants aged six months to 12 years. Initial participants are based in the United States but the biotech company said Canadian sites would be added as the trial progresses.
Expert advisory group says 3rd wave of pandemic is underway in Ontario.
Moderna begins COVID-19 vaccine trial in kids under the age of 12.
A health worker is seen near a COVID-19 patient in the intensive care unit of the Clinics Hospital in San Lorenzo, Paraguay, on Tuesday. Paraguay’s government has tightened restrictions due to an increase in COVID-19 cases, which has collapsed the country s health-care system.(Daniel Duarte/AFP/Getty Images)
AstraZeneca-Oxford COVID-19 vaccine now recommended for those 65 and older in Canada
Earlier this month, the committee, which makes recommendations on the use of newly approved vaccines in Canada, recommended that Canadians over 65 not receive an AstraZeneca-Oxford shot, while Health Canada, the regulator, had authorized its use in adults of all ages.
Moderna Inc said on Monday it had dosed the first participant in an early-stage study of a new COVID-19 vaccine candidate that could potentially be stored and shipped in refrigerators instead of freezers.
The latest on the coronavirus outbreak for March 15 cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Pfizer and BioNTech have submitted new temperature data to the U.S. health regulator that they said could allow their COVID-19 vaccine to be stored in pharmacy freezers at temperatures between –25 C and –15 C for up to two weeks.